hPSMA

品系全名

C57BL/6JSmo-Folh1tm1(hPSMA-Wpre-PA)Smoc

目录号

NM-HU-200240

品系状态

活体

导出PDF

基因信息

基因名
Folh1

品系描述

通过同源重组,将小鼠Folh1基因进行人源化修饰。

验证数据

image.png

Fig1. Detection of PSMA expression in kidney by RT-PCR. Wild type: only one band at 294 bp with primers F1/R1(mPsma);Heterozygous: one band at 294 bp with primers F1/R1(mPsma) and  one band at 169 bp with primers F2/R2(hPSMA); Abbr.. M, DNA marker; HO, homozygous; HE, heterozygous; WT, wild type.

image.png

Fig2. Detection of hPSMA expression in prostate in hPSMA KI mice.



NM-HU-200240 hPSMA-1.png

Fig3. Analysis of human PSMA expression in the MC38-hPSMA cell line and the transplanted tumor of the PSMA humanized mice by FACS. Most of the MC38-hPSMA cells express human PSMA (A,B);  the transplanted tumor formed by MC38-hPSMA cell line expresses human PSMA on the CD45- cells (C).(Completed in collaboration with CrownBio)

NM-HU-200240 hPSMA-2.png

Fig4. Subcutaneous tumor formation experiment of the MC38-hPSMA cells in the PSMA humanized mice .The tumor volume was measured every 5 days after injection of MC38-hPSMA cells (n=10).The previous studies have shown that wild type mice would spontaneously reject the syngeneic tumors  expressing an introduced human tumor antigen-hPSMA. While the MC38-hPSMA cells can form tumors subcutaneously in the humanized PSMA mice, indicating that the PSMA humanized mouse model can be used to transplant the MC38-hPSMA cell line.(Completed in collaboration with CrownBio)

image.png

Fig5. Detection of human PSMA expression in Prostate by IHC.

Note. The human PSMA antibody cross-reacted with mouse PSMA and human PSMA.  

Abbr. HO, homozygous; WT, wild type.



你也可能感兴趣

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

查看

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

查看

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

查看